LHC Group (NASDAQ:LHCG) is set to issue its quarterly earnings data after the market closes on Monday, November 6th. Analysts expect the company to announce earnings of $0.60 per share for the quarter. LHC Group has set its FY17 guidance at $2.30-2.40 EPS.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.09. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company had revenue of $260.20 million for the quarter, compared to analyst estimates of $254.10 million. During the same quarter in the prior year, the company posted $0.52 EPS. The business’s revenue for the quarter was up 15.1% compared to the same quarter last year. On average, analysts expect LHC Group to post $2.4 EPS for the current fiscal year and $2.64 EPS for the next fiscal year.

LHC Group (NASDAQ:LHCG) opened at 68.84 on Monday. LHC Group has a 52 week low of $32.04 and a 52 week high of $73.85. The firm’s 50 day moving average price is $67.20 and its 200-day moving average price is $63.20. The stock has a market cap of $1.26 billion, a price-to-earnings ratio of 30.46 and a beta of 0.76.

ILLEGAL ACTIVITY NOTICE: “LHC Group (LHCG) Scheduled to Post Quarterly Earnings on Monday” was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/10/30/lhc-group-lhcg-scheduled-to-post-quarterly-earnings-on-monday.html.

A number of equities analysts recently commented on LHCG shares. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $70.00 price objective on shares of LHC Group in a research note on Wednesday, September 6th. Bank of America Corporation started coverage on shares of LHC Group in a research note on Monday, August 21st. They issued a “buy” rating and a $76.00 price objective for the company. BidaskClub raised shares of LHC Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $68.00 price objective on shares of LHC Group in a research note on Friday, August 4th. Finally, Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $67.00 price objective for the company in a research note on Saturday, August 5th. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $66.60.

In other LHC Group news, COO Donald Dwayne Stelly sold 2,650 shares of LHC Group stock in a transaction on Friday, September 8th. The shares were sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the sale, the chief operating officer now owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 14.80% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Earnings History for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.